Abstract:

Angiotensin-converting enzyme inhibitors (ACEIs) are baseline drugs for the treatment of arterial hypertension (AH).Many original articles, reviews, and meta-analyses have been devoted to ACEIs and their effect on pathophysiological mechanisms and clinical efficacy, which unequivocally prove the positive role of these drugs in reducing overall mortality, the number of fatal and nonfatal cardiovascular events, and in preventing pathologic remodeling of certain organs and systems.